Skip to content

Dermagenics, Inc.

Country not established

Devices
1

What Dermagenics, Inc. makes

Dermagenics, Inc. manufactures the EPI-MAX, a device designed for microneedle radiofrequency skin remodeling to treat conditions such as wrinkles, scars, and skin laxity.

The EPI-MAX is classified as a Class II device under FDA regulations and is listed via the 510(k) pathway. The company is based in the United States.

AI-generated from registry data, 2 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue1

Newest first, rows 1-1 of 1

  • Epi-Max Ref K041059

    Active Regimes: 510(k) Registry: 510(k) Class:—

Frequently asked questions

How many devices does Dermagenics, Inc. have in the registry?

The registry currently lists 1 device for Dermagenics, Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Dermagenics, Inc.'s devices?

Among its 1 most recently registered device, Dermagenics, Inc. has devices listed in FDA 510(k) (1 device).

What are the newest devices from Dermagenics, Inc. in the registry?

The most recently registered devices listed for Dermagenics, Inc. include EPI-MAX.

Generated automatically from registry data and not verified by a human reviewer.